The bottom line is few companies can match its combination of established leadership in rare diseases and realistic pathways ...

However, Pfizer's revenue guidance for 2025 doesn't look particularly exciting. The company expects its top line to come in ...

The Dow, the S&P 500, and the Nasdaq Composite posted weekly gains, despite sliding in Friday's trading session, as the stock market digested President Trump's latest comments on tariffs.

The key for Philadelphia may have been persevering to garner the lead, albeit a precarious one at 16-15, when the snow really starting to pile up ... return down to the Rams 10-yard-line.

Johnson & Johnson (JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down ... in line with estimates. J&J reported total sales of $88.8 billion for 2024, up 4.3% ...

Investing.com -- Verizon (NYSE:VZ) on Friday reported better-than-expected earnings and revenue for the fiscal fourth quarter. The company's shares rose more than 1% in premarket trading. The ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 472.57% and ...

Shares of industrial conglomerate GE Aerospace (NYSE:GE) jumped 9.4% in the pre-market session after the ... double-digit revenue and EPS growth (in line with consensus) in FY 2025, with greater ...

Indian equity indices on Thursday ended on a positive note with Nifty at 23,200 on January 23. At close, the Sensex was up ...